Concepedia

Kate M. Moore

KM

Statistics

Publications

10

Citations

990

H-Index

10

Active since

2006

Affiliations

Queen Mary University of London(Current)

Cancer Research UK

Turku University Hospital

MRC Centre for Regenerative Medicine

AstraZeneca (United Kingdom)

Kate M. Moore is an author at Queen Mary University of London specializing in medicine, molecular oncology, and oncology.

ORCID

Publications per year

2006–2021

10

Publications

10

Extensive Hematopoietic Stem Cell Generation in the AGM Region via Maturation of VE-Cadherin+CD45+ Pre-Definitive HSCs

Samir Taoudi, Christèle Gonneau, Kate M. Moore et al. · Cell stem cell · 2008 · 284 citations · Full text

, , +16

Therapeutic Targeting of Integrin αvβ6 in Breast Cancer

Kate M. Moore, Gareth J. Thomas, Stephen W. Duffy et al. · JNCI Journal of the National Cancer Institute · 2014 · 145 citations · Full text

, , +10

The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy

Claire S. Reader, Sabari Vallath, Colin W. Steele et al. · The Journal of Pathology · 2019 · 111 citations · Full text

, , +16

Mouse extraembryonic arterial vessels harbor precursors capable of maturing into definitive HSCs

Sabrina Gordon-Keylock, Malgorzata Sobiesiak, Stanislav Rybtsov et al. · Blood · 2013 · 104 citations · Full text

, , +10

Suppression of TGF<sub>β</sub>and Angiogenesis by Type VII Collagen in Cutaneous SCC

Vera Martins, Matthew Caley, Kate M. Moore et al. · JNCI Journal of the National Cancer Institute · 2015 · 85 citations · Full text

, , +15

1–5 of 10